<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04397224</url>
  </required_header>
  <id_info>
    <org_study_id>2018-05-073</org_study_id>
    <nct_id>NCT04397224</nct_id>
  </id_info>
  <brief_title>Reduction or Extension of COnduction Time With Ventricular Electromechanical Remodeling (RECOVER)</brief_title>
  <acronym>RECOVER</acronym>
  <official_title>Prospective Multicenter Observation Study on the Serial Changes in Ventriculo-ventricular Conduction Times According to Cardiac-resynchronization Therapy Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective multicenter registry study aims to detect the serial changes in
      ventriculo-ventricular conduction times according to cardiac-resynchronization therapy
      response.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 20, 2018</start_date>
  <completion_date type="Anticipated">July 20, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 20, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serial change of ventriculo-ventricular conduction times</measure>
    <time_frame>from enrollment to last follow-up (2 years)</time_frame>
    <description>Reduction or extension of ventriculo-ventricular conduction times</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>CRT responder</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>CRT non-responder</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Device interrogation</intervention_name>
    <description>Ventriculo-ventricular conduction time measurement using device analyzer</description>
    <arm_group_label>CRT non-responder</arm_group_label>
    <arm_group_label>CRT responder</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patients implanted with multipoint pacing CRT device and quadripolar left
        ventricular lead from Abbott
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  meeting the current ESC or ACCF/AHA/HRS Class I or Class IIa indications for
             cardiac-resynchronization (CRT) implant

        Exclusion Criteria:

          -  Myocardial infarction, unstable angina within 40 days prior the enrollment

          -  Recent cardiac revascularization in the 4 weeks prior to the enrollment or planned for
             the 3 months following

          -  Cerebrovascular accident (CVA) or transient ischemic attack (TIA) in the 3 months
             prior to the enrollment

          -  Primary valvular disease requiring surgical correction

          -  Pregnant or are planning during the duration of the investigation

          -  Status 1 candidate for cardiac transplantation or consideration for transplantation
             over the next 12 months

          -  Post-cardiac transplantation

          -  Life expectancy &lt; 12 months

          -  Currently participating in any other clinical investigation except for observational
             registry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Seung-Jung Park</last_name>
    <phone>+82-2-3410-7145</phone>
    <email>orthovics@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sejong General Hospital</name>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang Weon Park</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samsung Changwon Medical Center</name>
      <address>
        <city>Changwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hye Bin Gwag</last_name>
      <phone>+82-55-2335821</phone>
      <email>tgfbk@naver.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun-Hyung Kim</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eulji University Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ki-Woon Kang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Il-young Oh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung-Jung Park</last_name>
      <phone>+82-2-3410-7145</phone>
      <email>orthovics@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 17, 2020</study_first_submitted>
  <study_first_submitted_qc>May 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>May 17, 2020</last_update_submitted>
  <last_update_submitted_qc>May 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

